Back to search resultsSummaryRMgm-1431
|
||||||||||
*RMgm-1431| Successful modification | The gene/parasite could not be changed/generated by the genetic modification. |
| The following genetic modifications were attempted | Gene disruption |
| Number of attempts to introduce the genetic modification | Unknown |
| Reference (PubMed-PMID number) |
Reference 1 (PMID number) : 23599312 |
| top of page | |
| Parent parasite used to introduce the genetic modification | |
| Rodent Malaria Parasite | P. berghei |
| Parent strain/line | P. berghei ANKA |
| Name parent line/clone | Not applicable |
| Other information parent line | |
| top of page | |
| Attempts to generate the mutant parasite were performed by | |
| Name PI/Researcher | Pulcini S; Tewari R; Krishna S |
| Name Group/Department | Division of Clinical Sciences |
| Name Institute | St. George's, University of London |
| City | London |
| Country | UK |
Disrupted: Mutant parasite with a disrupted gene| top of page | |||||||||||||||||||||||||
| Details of the target gene | |||||||||||||||||||||||||
| Gene Model of Rodent Parasite | PBANKA_0207000 | ||||||||||||||||||||||||
| Gene Model P. falciparum ortholog | PF3D7_0106300 | ||||||||||||||||||||||||
| Gene product | calcium-transporting ATPase | ||||||||||||||||||||||||
| Gene product: Alternative name | ATP6; SERCA; ATPase6 | ||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||
| Details of the genetic modification | |||||||||||||||||||||||||
| Inducable system used | No | ||||||||||||||||||||||||
| Additional remarks inducable system | |||||||||||||||||||||||||
| Type of plasmid/construct used | (Linear) plasmid double cross-over | ||||||||||||||||||||||||
| PlasmoGEM (Sanger) construct/vector used | No | ||||||||||||||||||||||||
| Modified PlasmoGEM construct/vector used | No | ||||||||||||||||||||||||
| Plasmid/construct map | |||||||||||||||||||||||||
| Plasmid/construct sequence | |||||||||||||||||||||||||
| Restriction sites to linearize plasmid | |||||||||||||||||||||||||
| Partial or complete disruption of the gene | Unknown | ||||||||||||||||||||||||
| Additional remarks partial/complete disruption | |||||||||||||||||||||||||
| Selectable marker used to select the mutant parasite | unknown | ||||||||||||||||||||||||
| Promoter of the selectable marker | unknown | ||||||||||||||||||||||||
| Selection (positive) procedure | unknown | ||||||||||||||||||||||||
| Selection (negative) procedure | No | ||||||||||||||||||||||||
| Additional remarks genetic modification | Unsuccessful attempts to disrupt or tag this gene indicates an essential role of ATP6 (SERCA) for growth/multiplication of blood stages. Limited information is provided in the paper on the genetic modification attempts: "Similarly, a double recombination construct failed to KO pbserca in the more tractable Plasmodium berghei system, and C-terminal tagging was also unsuccessful (data not shown). Also attempts to disrupt/tag the P. falciparum ortholog were unsuccessful. ATP6 is the only SERCA-type Ca2+-ATPase sequence in the Plasmodium genome. The protein is thought to be a P-type ATPase involved in calcium ion transport. Mutations in this gene has been related to artemisinin-resistance of malaria parasites but results from several studies indicate that PfATP6 is not directly involved in artemisinin action or resistance. | ||||||||||||||||||||||||
| Additional remarks selection procedure | |||||||||||||||||||||||||
|
Primer information: Primers used for amplification of the target sequences
![]() Primer information: Primers used for amplification of the target sequences
| |||||||||||||||||||||||||
| top of page | |||||||||||||||||||||||||